CytoDyn Inc. (CYDY) stock
CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026Market cap $345.56MP/E –Yield –
CytoDyn ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
CytoDyn's ebitda for the twelve months ending Aug 31, 2026 was -$40.18M. For fiscal 2026 it was -$38.56M, down 498.4% from the year before. The highest annual figure on record is $9.68M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | -$38.56M | -498.4% |
| FY2025 | May 31, 2025 | $9.68M | – |
| FY2024 | May 31, 2024 | -$18.03M | – |
| FY2023 | May 31, 2023 | -$40.40M | – |
| FY2022 | May 31, 2022 | -$144.62M | – |
| FY2021 | May 31, 2021 | -$102.80M | – |
| FY2020 | May 31, 2020 | -$72.61M | – |
| FY2019 | May 31, 2019 | -$54.61M | – |
| FY2018 | May 31, 2018 | -$45.56M | – |
| FY2017 | May 31, 2017 | -$26.96M | – |
| FY2016 | May 31, 2016 | -$20.81M | – |
| FY2015 | May 31, 2015 | -$19.24M | – |
| FY2014 | May 31, 2014 | -$7.76M | – |
| FY2013 | May 31, 2013 | -$7.77M | – |
| FY2012 | May 31, 2012 | -$7.45M | – |
| FY2011 | May 31, 2011 | -$3.70M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -$6.56M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -$5.64M | – |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$6.30M | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$21.68M | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$4.94M | -122.0% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -$5.06M | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$4.00M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$3.70M | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $22.44M | – |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -$6.63M | – |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$3.41M | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$3.39M | – |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$4.60M | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -$23.11M | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$9.61M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$78.92M | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$19.27M | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$25.07M | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$21.36M | – |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -$23.36M | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$30.27M | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | -$24.00M | – |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | -$25.06M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -$27.32M | – |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$21.57M | – |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | -$11.62M | – |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$12.10M | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | -$13.31M | – |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | -$12.37M | – |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | -$15.53M | – |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$13.40M | – |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -$11.11M | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | -$14.05M | – |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | -$10.69M | – |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | -$9.72M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -$7.71M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | -$7.93M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | -$6.06M | – |
| Q1 FY2017CQ3 2016 | Aug 31, 2016 | -$5.27M | – |
See a number that looks wrong?